Detection method for drug resistant genes of Klebsiella pneumoniae against belta-lactamase
A Klebsiella pneumoniae and lactamase technology, applied in biochemical equipment and methods, microbial determination/inspection, etc., can solve the problems of rising incidence of infection, increase of drug-resistant bacteria, inability to cure, etc. The effect of reducing infection rate, good social and economic benefits, and broad application prospects
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2009-09-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a gene detection method, in particular to a gene detection method for Klebsiella pneumoniae drug resistance to β-lactamase. Background technique
[0002] The history of the development of antibacterial drugs is a history of human beings fighting against bacteria. Humans continue to develop new drugs, and bacteria change their structures to fight against antibacterial drugs. The abuse of antibacterial drugs has led to an increasing proportion of drug-resistant bacteria, and the degree of drug resistance is getting higher and higher. The speed of new drug development is far behind the speed of bacterial drug resistance. Abuse of antimicrobials is a worldwide problem, especially in my country. According to statistics, the proportion of antimicrobial drugs used among inpatients in my country accounts for 60%-70% of inpatients, and only 20% in the United States. The abuse of antibacterial drugs has directly led to the increase of...
Examples
Embodiment Construction
[0051] 1 Materials and methods
[0052]1.1 Source and identification of strains
[0053] The 80 strains were all clinical samples isolated from patients between January 2006 and October 2007, including: 53 samples of sputum, 8 samples of urine, 4 samples of bile, 5 samples of pus, 4 samples of drainage fluid, and 3 samples of blood , 3 throat swabs. All strains were identified by ATB bacteria identification instrument and then sampled for later use.
[0054] 1.2 Antimicrobial susceptibility test
[0055] Drug susceptibility tests were performed in accordance with the requirements of the 2006 edition of CLSI in the United States. Quality control strains: Escherichia coli ATCC25922, Klebsiella pneumoniae ATCC700603, Pseudomonas aeruginosa ATCC27853, purchased from the Clinical Laboratory Center of the Ministry of Health.
[0056] 1.3 Drug susceptibility test
[0057] Broth microdilution method for antimicrobial susceptibility testing.
[0058] 1.4 β-lactamase gene detectio...